Current Studies
Study Information
Location
Status
Age Range
Sex
Max Compensation
ASCVD and Elevated LDL
A phase III study of an investigational medicine on major adverse CV events in patients with a history of ASCVD (atherosclerotic cardiovascular disease) events or at a high risk for a first event
Bowling Green
Evansville
Owensboro
Evansville
Owensboro
Enrolling
18+ yrs
Male/Female
Up to $1200
COPD
A phase III study to evaluate the efficacy and safety of an investigational medicine in adult participants with moderate to very severe chronic obstructive pulmonary disease.
Bowling Green
Owensboro
Owensboro
Enrolling
40-80 yrs
Male/Female
Up to $2600
Heart Failure Prevention
A phase III study to evaluate the efficacy and safety of investigational medicines compared with placebo in participants with type 2 diabetes, hypertension and established cardiovascular disease
Bowling Green
Enrolling
18+ yrs
Male/Female
Up to $3250
Heart Failure Prevention
A phase III, randomized, double-blind, placebo-controlled, Cardio-Vascular Outcomes Trial (CVOT) to evaluate the effect of an investigational medicine in combination with an approved medicine in participants with increased risk of developing heart failure
Owensboro
Enrolling
18+ yrs
Male/Female
Up to $1800
Osteoarthritis and Weight Loss
A phase 3 randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of once weekly investigational medicine in adult participants with osteoarthritis knee pain, and obesity or overweight
Evansville
Enrolling
18+ yrs
Male/Female
Up to $3999
Psoriatic Arthritis
A phase 2b, multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of an investigational medicine for the treatment of participants with active psoriatic arthritis
Evansville
Enrolling
18+ yrs
Male/Female
Up to $1200
COPD w/ Type2 Inflammation
A multicenter, randomized, double-blind, parallel group, placebo-controlled study of the efficacy and safety of early investigational initiation as add-on treatment in COPD patients with type 2 inflammation
Bowling Green
Coming Soon
40-75 yrs
Male/Female
Up to $1700
Hypertension
A phase 3 global, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of an investigational medicine in addition to standard of care in reducing major adverse cardiovascular events in adult patients with hypertension not adequately controlled and with either established cardiovascular disease or high risk for cardiovascular disease
Evansville
Coming Soon
18-55 yrs
Male/Female
TBD